Abstract:
PROBLEM TO BE SOLVED: To provide improved means for producing in vitro recombinant BMPs and other TGF-β family proteins using prokaryotic as well as eukaryotic host cells.SOLUTION: A fusion protein includes: a TGF-β family protein c-terminal seven-cysteine domain that is a component of latent TGF-β family protein, comprising N-terminal truncated TGF-β family protein, to refold under suitable refolding conditions, the truncated TGF-β family protein comprising a finger 1 subdomain, a finger 2 subdomain, and a heel subdomain; and a cleavable modified leader sequence operably linked to a TGF-β family protein C-terminal 7 domain, the leader sequence inhibiting the biological activity related to the C-terminal domain, and the C-terminal domain activating a portion or all of the leader sequence upon cleavage.
Abstract:
A surgical tool system is described that comprises a handpiece with a power generating unit capable of driving a cutting accessory or an implantable device that is fitted into a patient; and an attachment connectable to handpiece, the attachment serving as a linkage between the power generating unit and the cutting accessory or implantable device for driving the cutting accessory or the implantable device. The handpiece comprises a coil; and the attachment comprises a first coil positioned so that when the cutting accessory or implantable device is attached to the attachment, the first coil is able to receive signals from a coil internal to the cutting accessory or implantable device; and a second coil connected to the first coil and positioned so that when the attachment is attached to the handpiece, the second coil is able to transmit signals received from the cutting accessory or implantable device coil to the handpiece coil.
Abstract:
PROBLEM TO BE SOLVED: To provide a system and a delivery device for implanting a vaso-occlusive device for establishing an embolus or vascular occlusion in a vessel of a human or veterinary patient.SOLUTION: A device (60) for delivering an occlusive element includes an elongate sheath (64) having a lumen (66) therein. An elongate core member (68) is disposed within the lumen and is formed from a proximal portion (68a) and a distal portion (68b) connected via a joint (70). The distal portion of the elongate core member includes a severable junction (90) secured to the occlusive element. A marker coil (78) is coaxially arranged around the distal portion of the elongate core member and is partially disposed inside the sheath lumen. A coil member (80) is coaxially arranged around the distal portion of the elongate core member and coaxially arranged around at least a portion of the marker coil extending outside the lumen of the sheath. The coil member is secured at a distal end thereof to the distal portion of the elongate core member. The device resists axial compression while allowing for radial bending.
Abstract:
A system for controlling one or more medical devices by a remote console. The remote console communicates wirelessly with a central control unit that connects to one or more of the medical devices. To minimize the possibility that a medical device will be activated by a stray or unauthorized wireless command signal, the central control unit must synchronize with the remote console and establish a secure communication link with it before the central control unit will respond to a wireless command signal transmitted by the remote console.
Abstract:
PROBLEM TO BE SOLVED: To provide methods and devices for inducing formation of functional replacement nonarticular cartilage and ligament tissues. SOLUTION: The present invention provides methods and devices for inducing formation of functional replacement nonarticular cartilage and ligament tissues in this specification. The method and device include the use of osteogenic proteins and are useful in repairing defects in the larynx, trachea, interarticular menisci, intervertebral discs, ear, nose, ribs, or other fibrocartilaginous tissues in a mammal. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide treatments for preventing, inhibiting, retarding, or alleviating a perpetual or progressive loss of renal function resulting from acute renal failure. SOLUTION: The invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of, acute renal failure, or subjected to, or at risk of, inflammation, neutrophil-mediated cell damage, and apoptosis resulting from tissue damage or injury. The methods involve the administration of certain proteins of the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-β superfamily of proteins. COPYRIGHT: (C)2010,JPO&INPIT